HIVE DIGITAL TECHNOLOGIES LT (HIVE) Stock Fundamental Analysis
USA - NASDAQ:HIVE - CA4339211035 - Common Stock
2.8099 USD
-0.11 (-3.77%)
We assign a fundamental rating of 5 out of 10 to HIVE. HIVE was compared to 281 industry peers in the Software industry. HIVE scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. HIVE is growing strongly while it is still valued neutral. This is a good combination!
1. Profitability
1.1 Basic Checks
HIVE had positive earnings in the past year.
In the past year HIVE had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: HIVE reported negative net income in multiple years.
Each year in the past 5 years HIVE had a positive operating cash flow.
1.2 Ratios
The Return On Assets of HIVE (4.57%) is better than 72.24% of its industry peers.
HIVE's Return On Equity of 5.13% is fine compared to the rest of the industry. HIVE outperforms 69.75% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.57% | ||
| ROE | 5.13% | ||
| ROIC | N/A |
ROA(3y)-37.49%
ROA(5y)-16.27%
ROE(3y)-49.77%
ROE(5y)-22%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
HIVE has a better Profit Margin (22.36%) than 86.83% of its industry peers.
The Operating Margin and Gross Margin are not available for HIVE so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | 22.36% | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
HIVE does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for HIVE has been increased compared to 1 year ago.
The number of shares outstanding for HIVE has been increased compared to 5 years ago.
The debt/assets ratio for HIVE has been reduced compared to a year ago.
2.2 Solvency
An Altman-Z score of 5.60 indicates that HIVE is not in any danger for bankruptcy at the moment.
HIVE has a Altman-Z score of 5.60. This is in the better half of the industry: HIVE outperforms 77.22% of its industry peers.
A Debt/Equity ratio of 0.03 indicates that HIVE is not too dependend on debt financing.
The Debt to Equity ratio of HIVE (0.03) is better than 60.14% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.03 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 5.6 |
ROIC/WACCN/A
WACC10.12%
2.3 Liquidity
HIVE has a Current Ratio of 3.42. This indicates that HIVE is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 3.42, HIVE is in the better half of the industry, outperforming 79.72% of the companies in the same industry.
A Quick Ratio of 3.42 indicates that HIVE has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 3.42, HIVE belongs to the top of the industry, outperforming 80.43% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.42 | ||
| Quick Ratio | 3.42 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 145.17% over the past year.
HIVE shows a small growth in Revenue. In the last year, the Revenue has grown by 4.47%.
The Revenue has been growing by 31.59% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)145.17%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%500%
Revenue 1Y (TTM)4.47%
Revenue growth 3Y-18.07%
Revenue growth 5Y31.59%
Sales Q2Q%41.47%
3.2 Future
HIVE is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 78.85% yearly.
Based on estimates for the next years, HIVE will show a very strong growth in Revenue. The Revenue will grow by 53.13% on average per year.
EPS Next Y737.89%
EPS Next 2Y432.1%
EPS Next 3Y78.85%
EPS Next 5YN/A
Revenue Next Year189.49%
Revenue Next 2Y101.53%
Revenue Next 3Y53.13%
Revenue Next 5YN/A
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 21.61 indicates a rather expensive valuation of HIVE.
Based on the Price/Earnings ratio, HIVE is valued a bit cheaper than 68.68% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 25.07, HIVE is valued at the same level.
With a Price/Forward Earnings ratio of 5.62, the valuation of HIVE can be described as very cheap.
Based on the Price/Forward Earnings ratio, HIVE is valued cheaper than 94.31% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 34.08, HIVE is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 21.61 | ||
| Fwd PE | 5.62 |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
HIVE's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as HIVE's earnings are expected to grow with 78.85% in the coming years.
PEG (NY)0.03
PEG (5Y)N/A
EPS Next 2Y432.1%
EPS Next 3Y78.85%
5. Dividend
5.1 Amount
No dividends for HIVE!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NASDAQ:HIVE (11/21/2025, 11:28:47 AM)
2.8099
-0.11 (-3.77%)
Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)
Earnings (Next)
Inst Owners23.03%
Inst Owner Change37.63%
Ins Owners0.29%
Ins Owner Change0%
Market Cap666.99M
Revenue(TTM)128.65M
Net Income(TTM)28.76M
Analysts80
Price Target5.14 (82.92%)
Short Float %5.51%
Short Ratio0.36
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)185.32%
Min EPS beat(2)100.9%
Max EPS beat(2)269.73%
EPS beat(4)4
Avg EPS beat(4)130.87%
Min EPS beat(4)43.42%
Max EPS beat(4)269.73%
EPS beat(8)7
Avg EPS beat(8)88.66%
EPS beat(12)9
Avg EPS beat(12)16.46%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.88%
Min Revenue beat(2)-1.52%
Max Revenue beat(2)3.29%
Revenue beat(4)2
Avg Revenue beat(4)-0.05%
Min Revenue beat(4)-8.08%
Max Revenue beat(4)6.13%
Revenue beat(8)5
Avg Revenue beat(8)3.67%
Revenue beat(12)9
Avg Revenue beat(12)18.5%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)6.76%
PT rev (3m)10.17%
EPS NQ rev (1m)0%
EPS NQ rev (3m)54.55%
EPS NY rev (1m)2.85%
EPS NY rev (3m)349.94%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)14.87%
Revenue NY rev (1m)0.84%
Revenue NY rev (3m)10.54%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 21.61 | ||
| Fwd PE | 5.62 | ||
| P/S | 5.18 | ||
| P/FCF | N/A | ||
| P/OCF | 21.86 | ||
| P/B | 1.19 | ||
| P/tB | 1.19 | ||
| EV/EBITDA | N/A |
EPS(TTM)0.13
EY4.63%
EPS(NY)0.5
Fwd EY17.79%
FCF(TTM)-0.5
FCFYN/A
OCF(TTM)0.13
OCFY4.58%
SpS0.54
BVpS2.36
TBVpS2.36
PEG (NY)0.03
PEG (5Y)N/A
Graham Number2.63
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.57% | ||
| ROE | 5.13% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | 22.36% | ||
| GM | N/A | ||
| FCFM | N/A |
ROA(3y)-37.49%
ROA(5y)-16.27%
ROE(3y)-49.77%
ROE(5y)-22%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.2
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.03 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 206.22% | ||
| Cap/Sales | 116.51% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 3.42 | ||
| Quick Ratio | 3.42 | ||
| Altman-Z | 5.6 |
F-Score5
WACC10.12%
ROIC/WACCN/A
Cap/Depr(3y)97.27%
Cap/Depr(5y)157.57%
Cap/Sales(3y)54.64%
Cap/Sales(5y)58.11%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)145.17%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%500%
EPS Next Y737.89%
EPS Next 2Y432.1%
EPS Next 3Y78.85%
EPS Next 5YN/A
Revenue 1Y (TTM)4.47%
Revenue growth 3Y-18.07%
Revenue growth 5Y31.59%
Sales Q2Q%41.47%
Revenue Next Year189.49%
Revenue Next 2Y101.53%
Revenue Next 3Y53.13%
Revenue Next 5YN/A
EBIT growth 1Y-98.15%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year350.81%
EBIT Next 3Y65.08%
EBIT Next 5YN/A
FCF growth 1Y-313.96%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-33.66%
OCF growth 3Y-36.92%
OCF growth 5Y84.91%
HIVE DIGITAL TECHNOLOGIES LT / HIVE FAQ
Can you provide the ChartMill fundamental rating for HIVE DIGITAL TECHNOLOGIES LT?
ChartMill assigns a fundamental rating of 5 / 10 to HIVE.
What is the valuation status of HIVE DIGITAL TECHNOLOGIES LT (HIVE) stock?
ChartMill assigns a valuation rating of 5 / 10 to HIVE DIGITAL TECHNOLOGIES LT (HIVE). This can be considered as Fairly Valued.
Can you provide the profitability details for HIVE DIGITAL TECHNOLOGIES LT?
HIVE DIGITAL TECHNOLOGIES LT (HIVE) has a profitability rating of 3 / 10.
What is the earnings growth outlook for HIVE DIGITAL TECHNOLOGIES LT?
The Earnings per Share (EPS) of HIVE DIGITAL TECHNOLOGIES LT (HIVE) is expected to grow by 737.89% in the next year.